Trademark: 97690771
Word
ENOLEN
Status Date
Thursday, May 2, 2024
Filing Date
Wednesday, November 23, 2022
Published for Opposition
Tuesday, June 4, 2024
5 Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for delivery to solid organ tumors; implant subcutaneous drug delivery devices sold filled with pharmaceutical preparations for extended release of anti-androgen drugs directly to prostate tissue
10 Medical device for treating cancer
Nov 28, 2022
New Application Office Supplied Data Entered
Nov 26, 2022
New Application Entered
Sep 5, 2023
Assigned To Examiner
Sep 8, 2023
Non-Final Action Written
Sep 8, 2023
Non-Final Action E-Mailed
Sep 8, 2023
Notification Of Non-Final Action E-Mailed
Sep 12, 2023
Teas Response To Office Action Received
Sep 12, 2023
Correspondence Received In Law Office
Sep 13, 2023
Teas/Email Correspondence Entered
Mar 5, 2024
Correspondence Received In Law Office
Feb 16, 2024
Final Refusal Written
Feb 16, 2024
Final Refusal E-Mailed
Feb 16, 2024
Notification Of Final Refusal Emailed
Mar 5, 2024
Teas/Email Correspondence Entered
Mar 5, 2024
Teas Request For Reconsideration Received
Mar 6, 2024
Teas/Email Correspondence Entered
Mar 6, 2024
Correspondence Received In Law Office
Mar 6, 2024
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Mar 6, 2024
Action For Req For Recon Denied No Appeal Filed E-Mailed
Mar 6, 2024
Notification For Req For Recon Denied No Appeal Filed
Mar 6, 2024
Teas Request For Reconsideration Received
Apr 2, 2024
Action For Req For Recon Denied No Appeal Filed E-Mailed
Apr 2, 2024
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Apr 2, 2024
Notification For Req For Recon Denied No Appeal Filed
Apr 4, 2024
Correspondence Received In Law Office
Apr 30, 2024
Approved For Pub - Principal Register
May 15, 2024
Notification Of Notice Of Publication E-Mailed
Apr 4, 2024
Teas Request For Reconsideration Received
Apr 5, 2024
Teas/Email Correspondence Entered
Trademark Alertz updated from USPTO on 2030-01-24
